These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6170749)

  • 1. Effect of docusate sodium on drug release from a controlled-release dosage form.
    Chambliss WG; Cleary RW; Fischer R; Jones AB; Skierkowski P; Nicholes W; Kibbe AH
    J Pharm Sci; 1981 Nov; 70(11):1248-51. PubMed ID: 6170749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of regular and controlled-release chlorpheniramine products.
    Kotzan JA; Vallner JJ; Stewart JT; Brown WJ; Viswanathan CT; Needham TE; Dighe SV; Malinowski R
    J Pharm Sci; 1982 Aug; 71(8):919-23. PubMed ID: 7120098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro characterization of a controlled-release chlorpheniramine maleate delivery system prepared by the air-suspension technique.
    Mathir ZM; Dangor CM; Govender T; Chetty DJ
    J Microencapsul; 1997; 14(6):743-51. PubMed ID: 9394255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the Interaction Between an Ionic Surfactant and Polymer on the Dissolution of a Poorly Soluble Drug.
    Parikh V; Gumaste SG; Phadke S
    AAPS PharmSciTech; 2018 Oct; 19(7):3040-3047. PubMed ID: 30084069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of Surelease and sodium alginate on the in-vitro release of tamsulosin hydrochloride in pellet dosage form.
    Kim MS; Jun SW; Lee S; Lee TW; Park JS; Hwang SJ
    J Pharm Pharmacol; 2005 Jun; 57(6):735-42. PubMed ID: 15969928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug release from film-coated chlorpheniramine maleate nonpareil beads: water influx and development of a new drug release model.
    Tang L; Wigent RJ; Schwartz JB
    Pharm Dev Technol; 1999; 4(4):481-90. PubMed ID: 10578501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of chlorpheniramine maleate from fatty acid ester matrix disks prepared by melt-extrusion.
    Prapaitrakul W; Sprockel OL; Shivanand P
    J Pharm Pharmacol; 1991 Jun; 43(6):377-81. PubMed ID: 1681047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insight into modified release pellets - Internal structure and drug release mechanism.
    Ensslin S; Moll KP; Paulus K; Mäder K
    J Control Release; 2008 Jun; 128(2):149-56. PubMed ID: 18433911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymer-surfactant nanoparticles for sustained release of water-soluble drugs.
    Chavanpatil MD; Khdair A; Patil Y; Handa H; Mao G; Panyam J
    J Pharm Sci; 2007 Dec; 96(12):3379-89. PubMed ID: 17721942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyethylene Glycol 3350 and Docusate Sodium Compared With Docusate Sodium Alone After Urogynecologic Surgery: A Randomized Controlled Trial.
    Edenfield AL; Siddiqui NY; Wu JM; Dieter AA; Garrett MA; Visco AG
    Obstet Gynecol; 2016 Sep; 128(3):543-9. PubMed ID: 27500338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceruminolytic effects of docusate sodium: a randomized, controlled trial.
    Singer AJ; Sauris E; Viccellio AW
    Ann Emerg Med; 2000 Sep; 36(3):228-32. PubMed ID: 10969225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein bioactivity and polymer orientation is affected by stabilizer incorporation for double-walled microspheres.
    Kokai LE; Tan H; Jhunjhunwala S; Little SR; Frank JW; Marra KG
    J Control Release; 2010 Jan; 141(2):168-76. PubMed ID: 19751780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug release, preclinical and clinical pharmacokinetics relationships of alginate pellets prepared by melt technology.
    Bose A; Harjoh N; Pal TK; Dan S; Wong TW
    Expert Opin Drug Deliv; 2016; 13(1):143-54. PubMed ID: 26307229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once-a-day controlled-release dosage form of divalproex sodium II: development of a predictive in vitro drug release method.
    Qiu Y; Garren J; Samara E; Cao G; Abraham C; Cheskin HS; Engh KR
    J Pharm Sci; 2003 Nov; 92(11):2317-25. PubMed ID: 14603516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorpheniramine dissolution and relative urinary excretion from commercial products.
    Hsu HY; Ayres JW
    J Pharm Sci; 1989 Oct; 78(10):844-7. PubMed ID: 2600791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of dioctyl sodium sulfosuccinate on the absorption of tetracycline.
    Shah VP; Hunt JP; Fairweather WR; Prasad VK; Knapp G
    Biopharm Drug Dispos; 1986; 7(1):27-33. PubMed ID: 2420386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double controlled release of highly insoluble cilostazol using surfactant-driven pH dependent and pH-independent polymeric blends and in vivo bioavailability in beagle dogs.
    Nam KY; Cho SM; Choi YW; Park C; Meghani NM; Park JB; Lee BJ
    Int J Pharm; 2019 Mar; 558():284-290. PubMed ID: 30641181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DIOCTYL SODIUM SULFOSUCCINATE TABLET COATING.
    SCHALKER WL; VINCENT MC
    J Pharm Sci; 1964 Jul; 53():818-21. PubMed ID: 14209488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.